About Cannasat

Cannasat is a clinical stage pharmaceutical research and development company trading on the Toronto Venture Exchange (CTH-V). Cannasat is developing pharmaceutical products derived from naturally occurring and clinically proven molecules.

Latest News

August 12, 2008 - Cannasat Therapeutics Announces Closing of Private Placement
June 27, 2008 - Cannasat Therapeutics Grant of Options and Share Issuance
June 23, 2008 - Cannasat Therapeutics Receives $1.12 Million from Divesture of Prairie Plant Systems Equity Position
May 22, 2008 - Cannasat Therapeutics Reports Results for the Three Months Ended March 31, 2008
April 10, 2008 - Cannasat Therapeutics Reports Results for the Year Ended December 31, 2007

MORE NEWS...